Wordt geladen...
PARP Inhibitors: On the Horizon of Tailored and Personalized Therapies for Epithelial Ovarian Cancer
PURPOSE OF REVIEW: Management of the epithelial ovarian cancer (EOC) remains a therapeutic challenge, with continued poor overall survival. Given low chemotherapy response rates for recurrent disease and short survival times, new treatment options with improved therapeutic indices for targeting canc...
Bewaard in:
| Hoofdauteurs: | , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2012
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3799945/ https://ncbi.nlm.nih.gov/pubmed/22759740 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/CCO.0b013e3283564230 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|